Skip to contentN
Northwest Biotherapeutics Inc
N
NWBONorthwest Biotherapeutics Inc Q1 2016 · 10-Q
Revenue$236.00K$236.00K+21.6% vs Q1 2015 Net Income-$6.11M-$6.11MN/M vs Q1 2015 EPS Diluted-$0.06-$0.06N/M vs Q1 2015 Operating Income-$17,479,000N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Northwest Biotherapeutics Inc · CIK 1072379 · Engraved from SEC EDGAR
Margins · derivedOperating margin-7406.4%+4362.2 pt vs Q1 2015
Net margin-2587.3%+21347.2 pt vs Q1 2015
ended Mar 31, 2016 · filed May 11, 2016 · 41 d after period end